Healing Touch and Relaxation Therapies in Cervical Cancer Patients
Healing Touch in Advanced Cervical Cancer Patients: Immune Effects and Mechanisms
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to evaluate the effects of healing touch and relaxation therapy on cervical cancer patients undergoing chemotherapy and radiation treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Sep 2002
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2002
CompletedFirst Submitted
Initial submission to the registry
June 7, 2004
CompletedFirst Posted
Study publicly available on registry
June 8, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2007
CompletedJuly 10, 2009
July 1, 2009
4.6 years
June 7, 2004
July 9, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
natural killer cell cytotoxicity
Baseline to week 6
T-cell counts
Baseline to week 6
side effects
Baseline to week 6
Secondary Outcomes (4)
distress
Baseline to week 6
WBC and RBC
Baseline to week 6
days of treatment delay
Baseline to week 6
salivary cortisol
Baseline to post-treatment
Study Arms (3)
Healing Touch
EXPERIMENTALHealing Touch Therapy
Relaxation Therapy
ACTIVE COMPARATORRelaxation Therapy
Standard Care
PLACEBO COMPARATORStandard Care
Interventions
Eligibility Criteria
You may qualify if:
- Stage Ib1-IVa cervical cancer
- Treatment with concurrent chemotherapy and radiation at the University of Iowa Hospitals and Clinics
You may not qualify if:
- Immunosuppressive disorders
- Use of immunosuppressive medications
- Transplant recipient
- Metastatic or recurrent cervical cancer
- History of any other type of cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa Hospital and Clinics
Iowa City, Iowa, 52242, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan K Lutgendorf, MD
University of Iowa
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
June 7, 2004
First Posted
June 8, 2004
Study Start
September 1, 2002
Primary Completion
April 1, 2007
Study Completion
April 1, 2007
Last Updated
July 10, 2009
Record last verified: 2009-07